Inhalers are drug delivery devices that administer medication directly to the lungs, providing rapid onset of action for respiratory conditions while minimizing systemic exposure. Inhalation therapy is the cornerstone of asthma and chronic obstructive pulmonary disease management, delivering bronchodilators and anti-inflammatory agents directly to their site of action. The pulmonary route also offers potential for systemic drug delivery due to the large surface area and rich vascularization of the alveoli.

What Are Inhalers?

Inhalers generate an aerosol of drug particles small enough to penetrate the lower respiratory tract. The size of the particles determines where they deposit in the respiratory tree: particles larger than 5 micrometers deposit in the oropharynx, particles of 2 to 5 micrometers reach the conducting airways, and particles of 0.5 to 2 micrometers reach the alveoli. The fraction of the emitted dose that reaches the lungs, called the fine particle fraction, is a key determinant of inhaler efficiency.

Types of Inhalers

Metered-dose inhalers (MDIs) use a propellant to expel a measured dose of drug from a pressurized canister. Traditional MDIs used chlorofluorocarbon propellants, which have been replaced by hydrofluoroalkane propellants. MDIs require coordination between actuation and inhalation, and spacers or holding chambers are often used to improve drug delivery and reduce oropharyngeal deposition. The propellant evaporates rapidly after actuation, leaving drug particles suspended in the airstream.

Dry powder inhalers (DPIs) deliver medication as a dry powder that is aerosolized by the patient’s inspiratory effort. DPIs do not require propellants or coordination between actuation and inhalation, but they do require a sufficient inspiratory flow rate to deaggregate the powder and generate fine particles. Different DPI devices have different internal resistance, affecting the flow rate the patient can generate. Examples include the Diskus, Turbuhaler, and HandiHaler devices.

Nebulizers convert liquid drug solutions or suspensions into a fine mist that is inhaled through a mouthpiece or mask over several minutes. Nebulizers are used when patients cannot coordinate inhaler use, when high drug doses are needed, or when the drug is not available in an MDI or DPI formulation. Jet nebulizers use compressed gas, while ultrasonic and mesh nebulizers use vibrational energy to generate the aerosol. Nebulizers are less portable and require longer administration times than MDIs or DPIs.

When to Use

Inhalers are indicated primarily for respiratory conditions including asthma, chronic obstructive pulmonary disease, and cystic fibrosis. Inhaled beta-2 agonists provide rapid bronchodilation for acute symptoms, while inhaled corticosteroids provide maintenance anti-inflammatory therapy. Inhaled antibiotics are used for chronic respiratory infections in cystic fibrosis. The systemic route via inhalation is being explored for drugs such as insulin, levodopa, and certain vaccines, where rapid absorption and avoidance of first-pass metabolism are advantageous.

When Not to Use

Inhalers are not appropriate for patients who cannot generate sufficient inspiratory flow for DPIs or who cannot coordinate actuation and inhalation for MDIs without a spacer. Patients with severe cognitive impairment or physical limitations may require nebulized therapy instead. Inhalers are generally unsuitable for drugs that require precise systemic dosing or have a narrow therapeutic index, because pulmonary absorption is variable. Drugs that are irritating to the airways should not be administered by inhalation.

Advantages

Practical Benefits

• Direct delivery to the target organ allows lower doses than systemic administration
• Rapid onset of action for bronchodilators
• Portability and convenience with MDIs and DPIs
• No needles, making them preferred by patients averse to injections

Clinical Benefits

• Reduced systemic side effects compared to oral or intravenous administration
• Lower total drug dose required for equivalent therapeutic effect
• Bypass of first-pass metabolism for systemically absorbed fraction
• Ability to administer drug during acute respiratory symptoms

Disadvantages

Clinical Limitations

• Significant oropharyngeal deposition causes local side effects such as candidiasis and dysphonia
• Variable lung deposition depending on device technique and patient factors
• Inefficient delivery with only 10 to 30% of the dose reaching the lungs
• Some patients cannot generate adequate inspiratory flow for DPIs

Patient-Related Issues

• MDI requires coordination between actuation and inhalation
• Cleaning and maintenance requirements for devices
• Difficulty counting remaining doses in some devices
• Propellant taste or cold sensation with MDIs

Best Practices for Administration

MDI technique requires shaking the canister, exhaling fully, actuating while inhaling slowly and deeply, then holding the breath for 10 seconds. A spacer should be used to improve delivery and reduce oropharyngeal deposition. DPI technique varies by device but generally requires loading the dose, exhaling away from the device, and inhaling forcefully and deeply. Mouth rinsing with water after inhaled corticosteroid use reduces the risk of oral candidiasis and dysphonia.

Special Considerations

Patients using multiple inhaler types should use the bronchodilator first, then wait before using the corticosteroid inhaler. Spacers should be cleaned monthly with mild detergent and air-dried. DPIs must be stored in a dry environment, as moisture can cause powder clumping. Valved holding chambers reduce the need for coordination with MDIs and are particularly useful for children and elderly patients.

Conclusion

Inhalers are essential tools in the management of respiratory disease, offering targeted delivery with rapid onset and reduced systemic effects. Proper device selection and technique training are critical for optimal outcomes, and clinicians should regularly review and correct inhaler technique to ensure patients receive the full benefit of their medication.